Skip to main content
  • Boston Scientific delays Lotus valve commercialization

    Boston Scientific has announced a delay to its previously communicated timeline to make the Lotus Edge Aortic Valve System commercially available in Europe and the U.S.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details